SEC Form D · filed July 15, 2024
CASI Pharmaceuticals, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (31)
Thomas S. Souleles · Chicago, ILDirectorMichael J. Dolce · Chicago, ILExecWei (Larry) Y. Zhang · Beijing, IsraelExecKun Y. Qian · Beijing, IsraelExecBrendan J. Barrett · Chicago, ILExecZhenbo Su · Beijing, IsraelDirectorWei (Larry) Y. Zhang · Beijing, IsraelExecZhenbo Su · Beijing, IsraelDirectorAlexander Y. Wu · Rockville, MDDirectorAlexander A. Zukiwski · Rockville, MDExecJonathan C. Cohen · London, United KingdomDirectorXuebo Y. Zeng · Beijing, IsraelDirectorThomas Folinsbee · Beijing, IsraelDirectorBrandon J. Levitan · Chicago, ILDirectorChunhua Y. Wang · Beijing, IsraelExecTimothy P. Sullivan · Chicago, ILExecWei Y. Gao · Beijing, IsraelExecMatthew J. Denison · Chicago, ILExecChunhua Y. Wang · Beijing, IsraelExecWei Y. Gao · Beijing, IsraelExecWei-Wu He · Beijing, IsraelExec · DirectorAlexander A. Zukiwski · Rockville, MDExecXuebo Y. Zeng · Beijing, IsraelDirectorThomas Folinsbee · Beijing, IsraelDirectorAnnie S. Terry · Chicago, ILDirectorSandra Crane · London, United KingdomExec · DirectorKun Y. Qian · Beijing, IsraelExecWei-Wu He · ROCKVILLE, MDExec · DirectorAlexander Y. Wu · Rockville, MDDirectorHai Y. Huang · Beijing, IsraelExecHai Y. Huang · Beijing, IsraelExec Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗